Skip to search formSkip to main contentSkip to account menu

Metastatic Pancreatic Adenocarcinoma

An adenocarcinoma that arises from the exocrine pancreatic tissue and has metastasized to other anatomic sites.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Of the anticipated 50,000 individuals expected to be diagnosed with pancreatic cancer in 2016, the majority will have metastatic… 
Highly Cited
2010
Highly Cited
2010
4010 Background: In a randomized phase II trial of F vs G in 88 MPA patients (pts), we reported that F induces a response rate… 
2009
2009
Pancreatic adenocarcinoma is the fourth leading cause of cancer deaths in the United States. Current 5-year survival is less than… 
2008
2008
Background: No therapeutic standard of care exists for patients with advanced pancreatic cancer who progress following first-line… 
Highly Cited
2005
Highly Cited
2005
Not uncommonly, bile duct adenomas (BDAs) and hamartomas (BDHs) of the liver may be difficult to distinguish from metastatic well… 
Highly Cited
2004
Highly Cited
2004
4006 BACKGROUND: DX is a novel hexacyclic, water-soluble, topoisomerase-1 inhibitor. DX has single-agent and combination activity… 
2004
2004
Background: This study evaluates the maximum tolerated dose (MTD) and activity of mitomycin, docetaxel, and irinotecan (MDI… 
2001
2001
Tumor transmission or de novo tumor development in the transplanted organ is a rare event. Appreciation of the organ-specific… 
Highly Cited
2000
Highly Cited
2000
Although the novel cytidine analog gemcitabine has shown superior antitumor activity compared with weekly bolus 5‐fluorouracil in…